NIH accepting comments through May 26 on serology research priorities
The National Cancer Institute and National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, seek input through May 26 on research priorities for COVID-19 serology testing and related technologies, which are key to understanding immunity and developing vaccines against the virus.
The Paycheck Protection Program and Health Care Enhancement Act provides $306 million to NIH to develop, validate, improve and implement serological testing and associated technologies.
The agency intends to solicit applications for funding to establish Serological Sciences Centers of Excellence and projects to advance research on immune responses to the SARS-CoV-2 virus, including how it relates to cancer patients.
Related News Articles
Headline
In these video snippets from an AHA Advancing Health podcast series, health care leaders and clinicians from four children's hospitals share how they worked to…
Headline
Most health insurers must cover the updated COVID-19 vaccines from Pfizer and Moderna without cost sharing effective Sept. 11, when the Food and Drug…
Headline
The Department of Health and Human Services’ Administration for Strategic Preparedness and Response yesterday awarded $600 million for 12 domestic COVID-19…
Headline
AHA today participated in a Centers for Disease Control and Prevention Fall Immunization Kick-off Event for partner organizations, which focused on vaccinating…
Headline
AHA is providing its latest social media toolkit to help hospitals encourage vaccination against COVID-19. The newest toolkit includes messages and assets…
Headline
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…